Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model

PURPOSE: Pathologic corneal neovascularization is a major cause of blindness worldwide, and treatment options are currently limited. VEGF is one of the critical mediators of corneal neovascularization but current anti-VEGF therapies have produced limited results in the cornea. Thus, additional thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Michel M., Chan, Ann M., Law, Samuel M., Duarte, Sergio, Diaz-Aguilar, Daniel, Wadehra, Madhuri, Gordon, Lynn K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Cornea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336205/
https://www.ncbi.nlm.nih.gov/pubmed/30646013
http://dx.doi.org/10.1167/iovs.18-24345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336205/
https://www.ncbi.nlm.nih.gov/pubmed/30646013
http://dx.doi.org/10.1167/iovs.18-24345

Ejemplares similares